ReviewExpert review of neurotherapeutics2025

A critical review of brexpiprazole oral tablets as the first drug approved to treat agitation symptoms associated with dementia due to Alzheimer's disease.

Kate Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.